| Biomarker ID | 1551 |
| PMID | 25248617 |
| Year | 2014 |
| Biomarker | STEAP2 (Six transmembrane epithelial antigen of the prostate) |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in Low Risk Localised PCa (5.77 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: TGF-beta regulation of extracellular matrix, T cell receptor regulation of apoptosis |
| Experiment | Low Risk Localised PCa Vs Normal Tissue |
| Type of Biomarker | Diagnostic |
| Cohort | 4 patients with Low Risk PCa, High Risk PCa, 4 Locally Advanced PCa, 5 Metastatic Tumors and 4 Non Cancer controls were analysed for the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.022 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |